The SEC announced an award of more than $300,000 to a whistleblower whose high-quality information and continuing assistance significantly contributed to a successful enforcement action.
According to the press release, the whistleblower became aware of the potential securities law violations in connection with audit-related responsibilities. Although individuals with audit or compliance responsibilities are generally not eligible for awards, a whistleblower who reasonably believes that an entity is engaging in conduct that would impede the investigation falls within one of the exceptions to that rule. Here, the whistleblower had a reasonable basis to believe that the entity would impede the Commission’s investigation. This is the fourth time the agency has paid a whistleblower with internal audit or compliance related responsibilities.
Have a securities law question? Call Sallah Astarita & Cox at 212-509-6544.
- FINRA Reverses Hearing Panel Decision and Dismisses Complaint against Sallah Astarita & Cox client.
- Morgan Stanley Forcing You Back to the Office?
- Regulators Offer Free Resource to Securities Firms to Assist in Addressing Financial Exploitation of Seniors
- Silicon Valley Insider Trading Ring Charged
- Regulators Offer Resources to Firms to Assist in Detection, Prevention and Reporting of Financial Exploitation of Seniors
- SEC Charges Issuer With Cybersecurity Disclosure Controls Failures
- SEC Awards Approximately $3 Million to Two Whistleblowers
- Renee Jones to Join SEC as Director of Corporation Finance; John Coates Named SEC General Counsel
- SEC Chair Gensler Seeks to Amend 10b5-1
- SEC Charges Dentist-Turned-Investment Adviser for Three Separate Frauds
- SEC Announces Annual Regulatory Agenda
- Beware Phishing Email Using “gateway-finra.org” Domain Name
- SEC Updates List of Firms Using Inaccurate Information to Solicit Investors
- Gary Gensler Announces Additions to Executive Staff
- SEC Investor Advisory Committee to Meet Remotely On June 10
- SEC Charges Couple With Insider Trading on Confidential Clinical Trial Data